West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3028% above fair value
$404.02−10.10 (-2.44%)
Close on Nov 18, 2026Market cap $28.14BP/E 45.3Yield 0.21%
West Pharmaceutical Services pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
West Pharmaceutical Services's pe ratio was 52.9× on Nov 11, 2026, against 41.1× a year earlier. Over the last 5 years it ranged from 25.6× to 59.3×, with a median of 43.7×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 52.9× | +12.0 |
| 2025 | Dec 31, 2025 | 40.8× | −7.8 |
| 2024 | Dec 31, 2024 | 48.6× | +1.1 |
| 2023 | Dec 29, 2023 | 47.5× | +19.0 |
| 2022 | Dec 30, 2022 | 28.5× | −29.7 |
| 2021 | Dec 31, 2021 | 58.2× | −10.4 |
| 2020 | Dec 31, 2020 | 68.6× | +38.7 |
| 2015 | Jan 30, 2015 | 29.9× | −2.4 |
| 2014 | Dec 31, 2014 | 32.3× | +0.6 |
| 2013 | Dec 31, 2013 | 31.7× | +7.0 |
| 2012 | Dec 31, 2012 | 24.7× | +3.8 |
| 2011 | Dec 30, 2011 | 20.9× | +6.3 |
| 2010 | Jan 29, 2010 | 14.5× | −1.1 |
| 2009 | Dec 31, 2009 | 15.7× | – |
See a number that looks wrong?